Walgreens Boots Alliance, Inc. (NASDAQ:WBA) issued its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.10, Bloomberg Earnings reports. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the company earned $1.07 earnings per share. Walgreens Boots Alliance updated its FY18 guidance to $5.40-5.70 EPS.
Shares of Walgreens Boots Alliance (NASDAQ WBA) traded up $1.45 during mid-day trading on Friday, reaching $70.99. 12,380,900 shares of the company’s stock were exchanged, compared to its average volume of 5,343,083. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $70,204.04, a PE ratio of 13.64, a PEG ratio of 1.24 and a beta of 1.20. Walgreens Boots Alliance has a 1 year low of $63.82 and a 1 year high of $88.00.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 42.33%.
In related news, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 13.50% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Announces Quarterly Earnings Results” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright & trademark law. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2017/11/11/walgreens-boots-alliance-inc-wba-issues-earnings-results-beats-estimates-by-0-10-eps.html.
Walgreens Boots Alliance declared that its Board of Directors has initiated a share repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
WBA has been the topic of a number of research analyst reports. Pivotal Research reduced their target price on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a research report on Tuesday, October 24th. Loop Capital initiated coverage on Walgreens Boots Alliance in a research note on Thursday, August 24th. They set a “buy” rating and a $95.00 target price for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research note on Thursday, October 12th. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Finally, Royal Bank of Canada reissued a “buy” rating and issued a $88.00 price objective on shares of Walgreens Boots Alliance in a research report on Wednesday, October 25th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and a consensus target price of $87.63.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.